Literature DB >> 18520765

Urological issues in pediatric renal transplantation.

Shumyle Alam1, Curtis Sheldon.   

Abstract

PURPOSE OF REVIEW: The pediatric patient with end-stage renal disease provides a great opportunity for the involvement of the pediatric urologist because of the high incidence of associated urologic anomalies. RECENT
FINDINGS: Renal transplant remains the procedure of choice in the child with end-stage renal disease. The durability of survival of the graft is impacted by successful management of the genitourinary tract.
SUMMARY: Preoperative, intraoperative, and postoperative evaluation is critical for the child with associated urologic disease and end-stage renal disease. Early and appropriate management may stabilize renal function and prolong the time to transplant. Due to the relatively long life expectancy of children compared with adults with end-stage renal disease, appropriate management may be of benefit to avoid the morbidity associated with renal replacement therapy. In certain children, the appropriate management and reconstruction of the genitourinary tract may allow for a planned and preemptive renal transplant, thus avoiding dialysis.

Entities:  

Mesh:

Year:  2008        PMID: 18520765     DOI: 10.1097/MOU.0b013e328302ede7

Source DB:  PubMed          Journal:  Curr Opin Urol        ISSN: 0963-0643            Impact factor:   2.309


  3 in total

Review 1.  Primer on renal transplantation.

Authors:  Asha Moudgil
Journal:  Indian J Pediatr       Date:  2012-06-05       Impact factor: 1.967

2.  Chronic kidney disease and upper tract concerns after congenital and acquired urinary tract abnormalities: considerations for transition of care in teens and young adults.

Authors:  Elizabeth B Yerkes; Michelle Baum; David I Chu
Journal:  World J Urol       Date:  2020-06-08       Impact factor: 4.226

3.  Clinical practice recommendations for the care of infants with stage 5 chronic kidney disease (CKD5).

Authors:  Aleksandra M Zurowska; Michel Fischbach; Alan R Watson; Alberto Edefonti; Constantinos J Stefanidis
Journal:  Pediatr Nephrol       Date:  2012-10-09       Impact factor: 3.714

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.